臍帶血庫市場－全球產業規模、佔有率、趨勢、機會、預測：按服務、按組件、按應用、按行業、按地區和競爭對手分類，2021-2031年

全球臍帶血庫市場預計將從 2025 年的 201.1 億美元大幅成長至 2031 年的 392.3 億美元，複合年成長率為 11.78%。

這一成長主要得益於新生兒出生後從臍帶和胎盤中採集並冷凍保存造血幹細胞，用於各種治療用途。推動市場擴張的主要因素是白血病、淋巴瘤和鐮狀細胞貧血等慢性及遺傳性疾病發生率的不斷上升。這使得幹細胞移植成為一項至關重要的治療方法，預計2025年美國將新增66,890例白血病病例，進一步凸顯了這一點。此外，再生醫學和臨床研究的進步正在拓展臍帶血的效用，使其不再局限於傳統的血液疾病。一些研究顯示，臍帶血在治療腦性麻痺等神經系統疾病方面展現出良好的前景，這提升了其作為多功能生物資源的價值。除了應用範圍的不斷擴大，像FamiCord集團這樣的公司累計儲存超過一百萬份生物樣本的事實，也凸顯了市場對腦性麻痹的強勁需求，而這種需求是由已證實的臨床療效和新興的治療應用所驅動的。

市場促進因素

市場擴張的主要驅動力是可利用幹細胞治療的慢性病和遺傳性疾病的日益增加。白血病、淋巴瘤和鐮狀細胞貧血等疾病的增加，使得造血幹細胞移植的需求日益迫切，直接推動了臍帶血的保存。例如，美國癌症協會估計，到2025年，美國將新增66,890例白血病病例，這凸顯了對易於取得的幹細胞資源的迫切需求，並鼓勵家庭保存臍帶血作為「生物保險」。因此，像FamiCord集團這樣的行業領導者正在擴大業務，累計保存的生物材料已超過一百萬份。除了血液學應用之外，再生醫學和臨床研究的進步也在擴大市場範圍。發表在《兒科學》雜誌上的研究表明，臍帶血在治療神經系統疾病方面具有治療潛力，例如，腦性麻痹患者接受臍帶血治療後，其粗大運動技能得到了顯著改善。這些研究支持臍帶血在未來醫療干預中的效用，並促進孕婦和醫療保健專業人員更廣泛地採用臍帶血。

市場挑戰

全球臍帶血庫市場成長的主要障礙是私人臍帶血庫服務的高昂費用。除了每年的儲存費用外，家庭還必須承擔高額的初始採集和處理費用，這構成了一道巨大的經濟壁壘，限制了更多人群獲得臍帶血庫服務。由於缺乏統一的保險報銷政策，高昂的費用更難以負擔，迫使父母自行承擔全部費用，導致市場覆蓋範圍僅限於較為狹窄的富裕階層。此外，儲存資源的臨床利用率相對較低也加劇了這項經濟限制。例如，根據國際血液和骨髓移植研究中心（CIBMTR）的預測，到2025年，臍帶血僅佔異體移植的3%。如此低的利用率降低了潛在客戶對投資報酬率（ROI）的預期，直接阻礙了市場的進一步擴張。

市場趨勢

市場正呈現出對臍帶組織和胎盤庫服務多元化發展的顯著趨勢。各公司正將服務範圍擴展到傳統的造血幹細胞保存之外。透過保存臍帶組織和胎盤中所含的間質幹細胞，這些庫正在創造新的收入來源，並滿足日益成長的、以肌肉和神經修復為重點的再生醫學需求。這項策略不僅提高了每位客戶的終身價值，也緩解了因血液採集率停滯不前而帶來的壓力。 FamiCord集團就是一個典型的例子，該公司在2025年上半年實現了14.6%的收入成長，這主要得益於其成功的胎盤組織庫服務。同時，透過併購進行的策略性產業重組正在進行中，大型公司正在收購小型營業單位，重塑產業格局。長期冷凍保存的高昂固定成本和嚴格的監管要求，使得資金雄厚的集團公司更具優勢，它們能夠將庫業務整合到更廣泛的生殖醫學生態系統中，並創造交叉銷售機會。公司規模不斷擴大的趨勢也反映在庫柏公司等市場領導的財務表現。該公司旗下的庫柏外科部門預計2025會計年度營收將達到13.5億美元，充分展現了其透過整合醫療保健平台所建立的強大業務基礎。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球臍帶血庫市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 基於服務的服務（檢體儲存和處理、檢體檢體、檢體採集和運輸）
  • 依成分（臍帶血與臍帶組織）
  • 依應用領域（癌症、糖尿病、血液疾病、免疫系統疾病、代謝性疾病等）
  • 依部門分類（公立臍帶血庫與私立臍帶血庫）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章：北美臍帶血庫市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國別分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲臍帶血庫市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國別分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區臍帶血庫市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國別分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東與非洲臍帶血庫市場展望

• 市場規模及預測
• 市佔率及預測
• 中東與非洲：國別分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美臍帶血庫市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國別分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進因素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 近期趨勢

第13章：全球臍帶血庫市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的議價能力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Americord Registry LLC
• Covis Group
• Cordlife Group Limited
• Cryo-Cell International, Inc.
• FamiCord Group
• Perkinelmer Inc.
• Lifecell International Pvt. Ltd.
• ViaCord LLC
• Global Cord Blood Corporation
• StemCyte, Inc.

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Cord Blood Banking Market is projected to expand significantly from USD 20.11 Billion in 2025 to USD 39.23 Billion by 2031, demonstrating an 11.78% Compound Annual Growth Rate. This growth is underpinned by the practice of collecting and cryopreserving hematopoietic stem cells from the umbilical cord and placenta post-childbirth for various therapeutic uses. A primary catalyst for this market expansion is the escalating incidence of chronic hematological and genetic disorders such as leukemia, lymphoma, and sickle cell anemia, making stem cell transplantation a critical treatment, as evidenced by an estimated 66,890 new leukemia cases in the U.S. in 2025. Furthermore, advancements in regenerative medicine and clinical research are broadening cord blood's utility beyond traditional blood conditions, with studies demonstrating promising results for neurological conditions like cerebral palsy, thereby enhancing its perceived value as a versatile biological resource. This expanding scope, coupled with companies like FamiCord Group cumulatively storing over a million biological units, underscores the robust demand driven by its proven clinical efficacy and emerging therapeutic applications.

Market Driver

The market's expansion is significantly propelled by the increasing prevalence of chronic and genetic disorders treatable with stem cells. Conditions like leukemia, lymphoma, and sickle cell anemia are on the rise, creating a critical need for hematopoietic stem cell transplantation and directly incentivizing cord blood storage. For instance, the American Cancer Society reported an estimated 66,890 new leukemia cases in the U.S. in 2025, highlighting the urgent demand for readily available stem cell resources and prompting families to bank cord blood as a biological insurance. Consequently, leading industry players, such as the FamiCord Group, have scaled their operations, cumulatively storing over one million units of biological material. Beyond hematological uses, advancements in regenerative medicine and clinical research are broadening the market's scope. Promising research into cord blood's therapeutic potential for neurological conditions, like the significant improvements in gross motor skills observed in cerebral palsy patients treated with cord blood as published in Pediatrics, validates its utility for future medical interventions and encourages wider adoption among expectant parents and healthcare providers.

Market Challenge

A primary challenge hindering the growth of the Global Cord Blood Banking Market is the prohibitive cost associated with private banking services. Families face substantial initial collection and processing fees, followed by recurring annual storage charges, which collectively create a significant financial barrier that restricts accessibility for a broad demographic. This high expense is further compounded by the lack of uniform insurance reimbursement policies, forcing parents to bear the full cost out-of-pocket and effectively limiting the market's reach to a narrower, affluent segment. Moreover, this economic restraint is intensified by the relatively low clinical application rate of these preserved resources; for example, umbilical cord blood represented only 3% of allogeneic transplants in 2025, according to the Center for International Blood and Marrow Transplant Research. This low utilization undermines the perceived return on investment for prospective customers, directly impeding broader market expansion.

Market Trends

The market is witnessing a notable trend in the diversification into cord tissue and placental banking services, where companies are expanding their offerings beyond traditional hematopoietic stem cell storage. By preserving mesenchymal stem cells found in umbilical cord tissue and the placenta, banks are creating new revenue streams and meeting the growing demand for regenerative therapies focused on muscle and nerve repair. This strategy not only increases the lifetime value derived from each client but also mitigates pressure from stagnant blood collection rates, as exemplified by FamiCord Group's 14.6% revenue increase in H1 2025, largely driven by its successful placental tissue banking services. Simultaneously, strategic industry consolidation through mergers and acquisitions is reshaping the sector, as major players absorb smaller entities to enhance operational efficiency. The high fixed costs associated with long-term cryopreservation and stringent regulatory compliance favor well-capitalized conglomerates that can integrate banking into broader reproductive health ecosystems, thereby enabling cross-selling opportunities. This trend toward significant corporate scale is reflected in the financial results of market leaders like CooperCompanies, whose CooperSurgical division reported $1.35 billion in fiscal year revenue in 2025, showcasing the robust capacity achieved through these integrated healthcare platforms.

Key Market Players

• Americord Registry LLC
• Covis Group
• Cordlife Group Limited
• Cryo-Cell International, Inc.
• FamiCord Group
• Perkinelmer Inc.
• Lifecell International Pvt. Ltd.
• ViaCord LLC
• Global Cord Blood Corporation
• StemCyte, Inc.

Report Scope

In this report, the Global Cord Blood Banking Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cord Blood Banking Market, By Service

• Sample Preservation & Storage
• Sample Analysis
• Sample Processing
• Sample Collection
• Transportation

Cord Blood Banking Market, By Component

• Cord Blood
• Cord Tissue

Cord Blood Banking Market, By Application

• Cancer Disease
• Diabetes
• Blood Disease
• Immune Disorders
• Metabolic Disorders
• Others

Cord Blood Banking Market, By Sector

• Public Cord Blood Banks
• Private cord Blood Banks

Cord Blood Banking Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Cord Blood Banking Market.

Available Customizations:

Global Cord Blood Banking Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cord Blood Banking Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Service (Sample Preservation & Storage, Sample Analysis, Sample Processing, Sample Collection & Transportation)
  • 5.2.2. By Component (Cord Blood v/s Cord Tissue)
  • 5.2.3. By Application (Cancer Disease, Diabetes, Blood Disease, Immune Disorders, Metabolic Disorders, Others)
  • 5.2.4. By Sector (Public Cord Blood Banks v/s Private cord Blood Banks)
  • 5.2.5. By Region
  • 5.2.6. By Company (2025)
• 5.3. Market Map

6. North America Cord Blood Banking Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Service
  • 6.2.2. By Component
  • 6.2.3. By Application
  • 6.2.4. By Sector
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Cord Blood Banking Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Service
      • 6.3.1.2.2. By Component
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By Sector
  • 6.3.2. Canada Cord Blood Banking Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Service
      • 6.3.2.2.2. By Component
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By Sector
  • 6.3.3. Mexico Cord Blood Banking Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Service
      • 6.3.3.2.2. By Component
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By Sector

7. Europe Cord Blood Banking Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Service
  • 7.2.2. By Component
  • 7.2.3. By Application
  • 7.2.4. By Sector
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Cord Blood Banking Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Service
      • 7.3.1.2.2. By Component
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By Sector
  • 7.3.2. France Cord Blood Banking Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Service
      • 7.3.2.2.2. By Component
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By Sector
  • 7.3.3. United Kingdom Cord Blood Banking Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Service
      • 7.3.3.2.2. By Component
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By Sector
  • 7.3.4. Italy Cord Blood Banking Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Service
      • 7.3.4.2.2. By Component
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By Sector
  • 7.3.5. Spain Cord Blood Banking Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Service
      • 7.3.5.2.2. By Component
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By Sector

8. Asia Pacific Cord Blood Banking Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Service
  • 8.2.2. By Component
  • 8.2.3. By Application
  • 8.2.4. By Sector
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Cord Blood Banking Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Service
      • 8.3.1.2.2. By Component
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By Sector
  • 8.3.2. India Cord Blood Banking Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Service
      • 8.3.2.2.2. By Component
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By Sector
  • 8.3.3. Japan Cord Blood Banking Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Service
      • 8.3.3.2.2. By Component
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By Sector
  • 8.3.4. South Korea Cord Blood Banking Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Service
      • 8.3.4.2.2. By Component
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By Sector
  • 8.3.5. Australia Cord Blood Banking Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Service
      • 8.3.5.2.2. By Component
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By Sector

9. Middle East & Africa Cord Blood Banking Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Service
  • 9.2.2. By Component
  • 9.2.3. By Application
  • 9.2.4. By Sector
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Cord Blood Banking Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Service
      • 9.3.1.2.2. By Component
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By Sector
  • 9.3.2. UAE Cord Blood Banking Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Service
      • 9.3.2.2.2. By Component
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By Sector
  • 9.3.3. South Africa Cord Blood Banking Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Service
      • 9.3.3.2.2. By Component
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By Sector

10. South America Cord Blood Banking Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Service
  • 10.2.2. By Component
  • 10.2.3. By Application
  • 10.2.4. By Sector
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Cord Blood Banking Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Service
      • 10.3.1.2.2. By Component
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By Sector
  • 10.3.2. Colombia Cord Blood Banking Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Service
      • 10.3.2.2.2. By Component
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By Sector
  • 10.3.3. Argentina Cord Blood Banking Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Service
      • 10.3.3.2.2. By Component
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By Sector

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Cord Blood Banking Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Americord Registry LLC
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Covis Group
• 15.3. Cordlife Group Limited
• 15.4. Cryo-Cell International, Inc.
• 15.5. FamiCord Group
• 15.6. Perkinelmer Inc.
• 15.7. Lifecell International Pvt. Ltd.
• 15.8. ViaCord LLC
• 15.9. Global Cord Blood Corporation
• 15.10. StemCyte, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer